Patients with ABCA7 single nucleotide polymorphisms (SNPs) are more likely to develop AD, suggesting that a functional ABCA7 transporter is crucial for protecting against AD onset, possibly through its interaction with cell membrane lipids and mediation of cholesterol transport [6]. Here, ABCA7 is linked to Alzheimer disease.